
tcY-NH2
CAS No. 327177-34-4
tcY-NH2 ( —— )
产品货号. M30778 CAS No. 327177-34-4
Selective PAR4 antagonist peptide. Inhibits endostatin release and platelet aggregation induced by thrombin.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称tcY-NH2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Selective PAR4 antagonist peptide. Inhibits endostatin release and platelet aggregation induced by thrombin.
-
产品描述Selective PAR4 antagonist peptide. Inhibits endostatin release and platelet aggregation induced by thrombin.
-
体外实验tcY-NH2 (0-500 μM) inhibits AYPGKF-NH2 (10 μM)-induced platelet (obtained from male albino Sprague–Dawley rats) aggregation, with an IC50 value of 95 μM.tcY-NH2 potently activates aorta relaxation (RA) and gastric (LM) contraction, with IC50 values of 64 μM (RA) and 1 μM (LM).tcY-NH2 (Tc-YPGKF-NH2, 400 μM, 5 min) prevents endostatin release and platelet aggregation induced by thrombin or by AY-NH2.tcY-NH2 (5 μM, 15 min) decreases infarct size (IS) by 51%, and increases recovery of ventricular function by 26% in an isolated heart model.
-
体内实验tcY-NH2 (tail vein injection, 0.6 mg/kg for a single dose) alleviates liver injury in Brain death (BD) rat model, indicated by lower serum ALT/AST levels and better histomorphology.tcY-NH2 (intraperitoneal injection, 0.6 mg/kg for a single dose) increases posttraumatic activation of CD4+ Tregs within the draining lymph nodes in burn injury mice model .tcY-NH2 (intrapleural injection, 40 ng/kg for a single dose) inhibits neutrophil recruitment in experimental inflammation in mice. Animal Model:Brain death (BD) rat model Dosage:0.6 mg/kg for a single doseAdministration:Tail vein injection for a single dose Result:Reduced blood platelet activation and hepatic platelet accumulation.Attenuated the inflammatory response and apoptosis in the livers.Inhibited the activation of NF-κB and MAPK pathways induced by Brain death (BD).Animal Model:Burn injury model of C57BL/6 N mice Dosage:0.6 mg/kg for a single dose Administration:Intraperitoneal injection Result:Increased expression and phosphorylation of PKC-θ in the presence of platelets, without affecting early posttraumatic hemostasis.Animal Model:BALB/c mice Dosage:40 ng/kg for a single dose Administration:Intrapleural injection Result:Abolished the number of rolling and adhering neutrophils on the vessel wall.Inhibited CXCL8- and Cg-induced neutrophil migration into the pleural cavity of mice.
-
同义词——
-
通路GPCR/G Protein
-
靶点PAR
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number327177-34-4
-
分子量739.87
-
分子式C40H49N7O7
-
纯度>98% (HPLC)
-
溶解度water:1 mg/mL
-
SMILESNCCCC[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)\C=C\C1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hollenberg et al (2004) Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br.J.Pharmacol. 143 443 PMID:
产品手册




关联产品
-
PAR-4 Agonist Peptid...
PAR-4 agonist peptide stimulates thromboxane production by human platelets with the maximal response to this agonist being approximately half of that observed after maximal thrombin stimulation.
-
Thrombin Receptor Ac...
肽凝血酶受体激活剂也称为凝血因子 II 受体 (1-5) 或蛋白酶激活受体 1 (1-5),用于冠心病 (CHD) 的研究。
-
Atopaxar
一种有效的、可逆的 PAR-1 拮抗剂,IC50 为 19 nM;对凝血酶和 TRAP 诱导的人血小板聚集具有有效的抑制作用,IC50 分别为 64 nM 和 31 nM。